This trial is to see what effects a single dose of ZTI-01 has on children under the age of 12, and to compare those effects to adults who have received a 6g dose of the drug. The study will help establish an appropriate dosing for younger children by age cohort.
1 Primary · 2 Secondary · Reporting Duration: From time end of 1-hour infusion on Day 1, up to 8-12 hours post infusion on Day 1
21 Total Participants · 5 Treatment Groups
Primary Treatment: ZTI-01 100 mg/kg · No Placebo Group · Phase 1
Age < 18 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: